Legence Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Revenue	2,361	2,099	1,615	1,247
Revenue Growth (YoY)	46.19%	29.94%	29.57%	-
Cost of Revenue	1,860	1,668	1,300	1,013
Gross Profit	501.38	430.77	315.15	233.71
Selling, General & Admin	286.91	239.34	184.45	141.03
Operating Expenses	388.94	336.49	264.69	223.54
Operating Income	112.44	94.27	50.46	10.17
Interest Expense	-114.45	-91.61	-68.2	-50.84
Interest & Investment Income	3.7	5.46	4.25	0.24
Earnings From Equity Investments	0.78	3.06	1.33	-
Other Non Operating Income (Expenses)	-6.37	-7.33	-0.56	-0.51
EBT Excluding Unusual Items	-3.9	3.86	-12.72	-40.94
Merger & Restructuring Charges	-4.96	-9.18	-5.4	-6.66
Impairment of Goodwill	-17.8	-17.8	-5.05	-23.44
Other Unusual Items	-5.69	-	-30.77	-3.62
Pretax Income	-32.15	-23.12	-53.94	-74.66
Income Tax Expense	8.68	4.52	-7.92	7.61
Earnings From Continuing Operations	-40.83	-27.64	-46.03	-82.27
Minority Interest in Earnings	-4.94	-0.91	-	-
Net Income	-45.76	-28.56	-46.03	-82.27
Net Income to Common	-19.78	-28.56	-46.03	-82.27
Free Cash Flow	137.2	10.26	16.84	0.68
Gross Margin	21.23%	20.53%	19.51%	18.75%
Operating Margin	4.76%	4.49%	3.12%	0.82%
Profit Margin	-0.84%	-1.36%	-2.85%	-6.60%
Free Cash Flow Margin	5.81%	0.49%	1.04%	0.06%
EBITDA	227.91	205.12	143.26	103.19
EBITDA Margin	9.65%	9.77%	8.87%	8.28%
D&A For EBITDA	115.47	110.85	92.8	93.02
EBIT	112.44	94.27	50.46	10.17
EBIT Margin	4.76%	4.49%	3.12%	0.82%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q